Over 80% of bacterial infections in humans are caused by harmful biofilms and these biofilms could be prevented. Inspired by the natural biology of the red seaweed Delisea pulchra, Remora is a unique and sustainable solution to harmful biofilms.
Our award-winning technology stops biofilm formation at its earliest stages, offering a highly effective solution for multiple sectors. By preventing harmful biofilms forming in the first place, Remora reduces bacterial infections, material degradation, and persistent contamination, ensuring cleaner, safer and more durable environments.
Remora was created by Penrhos Bio, following a decade-long collaboration and significant investment from Unilever, as well as wider support from a range of UK universities and research bodies. This patented technology effectively and sustainably blocks biofilm formation in a wide range of applications, including textiles, paints and coatings and healthcare settings.
Keen to have a chat? Get in touch today!
Company Details
- Employees
- 8
- Address
- 5-7 Cranwood Street, Finsgate,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://penrhosbio.com/remora/
- Keywords
- in sustainable textile protection.
- HQ
- London, England
Remora Questions
Remora's website is https://penrhosbio.com/remora/
Remora's LinkedIn profile is https://uk.linkedin.com/company/remora-bio
Remora has
8 employees.
View email and phone details for 8
employees at Remora.
Remora's industry is
Biotechnology Research
Remora's top competitors are
Remora Biotech,
Sensor Innovations Ltd,
Mialgae,
Concinnity Genetics,
Martin-Baker Aircraft Co Ltd,
Cellmine,
Domainex,
Remora Technology,
Novarum,
Science Entrepreneur Club.
Remora's categories are Biotechnology Research
